Tenax Therapeutics, Inc. TENX

1.81 (0.08) (4.23%) as of 25 Sep
Market cap
$70.0M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(59.80%) (51.71%) (55.64%) (44.80%)

+8 more TTM periods

ROA
(57.02%) (49.23%) (52.36%) (42.77%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(57.10%) (50.49%) (54.19%) (45.03%)
Average Days of Receivables
— — — —
Free Cash Flow per Share
(0.90) (0.84) (0.91) (0.65)
Free Cash Flow
(46.03) (38.14) (35.80) (25.91)
Other line items
Cash ROIC
(19.88%) (16.34%) (18.39%) (13.25%)
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% —
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.71 0.66 0.68 0.60
Depreciation/Fixed assets
— — — 0.00
Capex/Depreciation
— — — 0.00
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.90) (0.84) (0.91) (0.65)
Capex per Share
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates